These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1649357)
1. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro. Farnen JP; Tyrkus M; Hanson CA; Cody RL; Emerson SG Leukemia; 1991 Jul; 5(7):574-84. PubMed ID: 1649357 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line. Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862 [TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a CD5 positive, immunosuppressive human myeloma cell line. Scibienski RJ; Paglieroni TG; MacKenzie MR Leukemia; 1990 Nov; 4(11):775-80. PubMed ID: 1700238 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules. Pilarski LM; Jensen GS Hematol Oncol Clin North Am; 1992 Apr; 6(2):297-322. PubMed ID: 1533857 [TBL] [Abstract][Full Text] [Related]
5. An antigenic study of human plasma cells in normal tissue and in myeloma: identification of a novel plasma cell associated antigen. Nathan PD; Walker L; Hardie D; Richardson P; Khan M; Johnson GD; Ling NR Clin Exp Immunol; 1986 Jul; 65(1):112-9. PubMed ID: 3024883 [TBL] [Abstract][Full Text] [Related]
6. Lactate dehydrogenase production and release in a newly established human myeloma cell line. Hatakeyama N; Daibata M; Nemoto Y; Ohtsuki Y; Taguchi H Am J Hematol; 2001 Apr; 66(4):267-73. PubMed ID: 11279638 [TBL] [Abstract][Full Text] [Related]
7. Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels. Pilarski LM; Ruether BA; Mant MJ J Clin Invest; 1985 Jun; 75(6):2024-9. PubMed ID: 2989339 [TBL] [Abstract][Full Text] [Related]
8. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021 [TBL] [Abstract][Full Text] [Related]
9. [Establishment and biological characteristics of human multiple myeloma cell line CZ-1]. Hou J; Zhang B; Zhang L; Ding S Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):509-13. PubMed ID: 12482345 [TBL] [Abstract][Full Text] [Related]
10. The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma. Waldmann TA; Broder S; Krakauer R; MacDermott RP; Durm M; Goldman C; Meade B Fed Proc; 1976 Jul; 35(9):2067-72. PubMed ID: 1084293 [TBL] [Abstract][Full Text] [Related]
11. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1). Togawa A; Inoue N; Mannoji M; Namba M Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374 [TBL] [Abstract][Full Text] [Related]
12. Establishment of Epstein-Barr virus-negative diffuse large cell lymphoma cell line with an 8;22 chromosomal translocation. Ichinose I; Nakano S; Ohshima K; Mitsugi K; Anzai K; Shida T; Niho Y Cancer Res; 1991 Oct; 51(19):5392-7. PubMed ID: 1913659 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-transformed B-cell line (DV-1) derived from bone marrow of a patient with severe combined immunodeficiency and immunoblastic lymphoma. Rosenblatt HM; Lewis DE; Sklar J; Cleary ML; Parikh N; Galili N; Ritz J; Shearer WT Pediatr Res; 1987 Apr; 21(4):331-7. PubMed ID: 3033590 [TBL] [Abstract][Full Text] [Related]
15. Immature B cells in fetal development and immunodeficiency: studies of IgM, IgG, IgA and IgD production in vitro using Epstein-Barr virus activation. Pereira S; Webster D; Platts-Mills T Eur J Immunol; 1982 Jul; 12(7):540-6. PubMed ID: 6288397 [TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma: an immunologic profile. IV. The EA rosette-forming cell is a Leu-1 positive immunoregulatory B cell. MacKenzie MR; Paglieroni TG; Warner NL J Immunol; 1987 Jul; 139(1):24-8. PubMed ID: 2953812 [TBL] [Abstract][Full Text] [Related]
18. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin. Matsuo Y; Drexler HG; Harashima A; Okochi A; Hasegawa A; Kojima K; Orita K Leuk Res; 2004 Aug; 28(8):869-77. PubMed ID: 15203285 [TBL] [Abstract][Full Text] [Related]
19. Establishment and biological characteristics of human multiple myeloma cell line CZ-1. Hou J; Lin FY; Zhang B; Zhang LZ; Ding SQ Chin Med J (Engl); 2004 Jan; 117(1):115-9. PubMed ID: 14733786 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines. Commes T; Clofent G; Ghanem N; Zhang XG; Lefranc MP; Bataille R; Klein B Leukemia; 1993 Apr; 7(4):609-17. PubMed ID: 7681918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]